DETERMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS IN A COMBINED INFUSION SOLUTION BY HPLC: METHOD DEVELOPMENT AND VALIDATION

DETERMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS IN A COMBINED INFUSION SOLUTION BY HPLC: METHOD DEVELOPMENT AND VALIDATION

Authors

DOI:

https://doi.org/10.55475/jcgtm/vol5.iss5.2026.700

Keywords:

HPLC, method validation, monoammonium glycyrrhizinate, infusion solution, hepatoprotective agent, ICH Q2(R1)

Abstract

Two HPLC methods for the determination of monoammonium glycyrrhizinate, glycine, and L-cysteine hydrochloride in the combined infusion solution «GEPA-SEEM» were developed and fully validated in accordance with ICH Q2(R1). Both methods demonstrated high precision (RSD ≤ 0.22%), accuracy (recovery 98.5–101.5%), and linearity (R² > 0.999). Based on the results, an in-house pharmacopoeial monograph was established for the product.

Author Biographies

Sunnatulla U. Tugizboev, QK MAS'UL. JAM. «SAMARKAND-ENGLAND ECO-MEDICAL»

Master's student at the Department of Inorganic Chemistry and Materials Science

G'olib K. Toshev, QK MAS'UL. JAM. «SAMARKAND-ENGLAND ECO-MEDICAL»

Quality Director

Charos T. Toshtemirova, Tashkent Pharmaceutical Institute

Acting Associate Professor, PhD, Department of Pharmaceutical Chemistry

Volidakhon G. Umirdinova, Tashkent Pharmaceutical Institute

Independent Researcher at the Department of Pharmaceutical Chemistry

Sevara M. Xazratqulova, Tashkent Pharmaceutical Institute

PhD in Chemistry, Associate Professor, Department of Physical and Colloid Chemistry

References

Parenteral dori vositalarining sifatini nazorat qilish ularning xavfsizligi va samaradorligini ta'minlashning asosiy sharti hisoblanadi. Vena ichiga yuboriladigan infuzion eritmalar eng qat'iy sifat talablariga — sterillik, apirogenligi va FFIlarning aniq dozalanishiga — javob berishi shart [1, 2]. Shuning uchun har qanday yangi farmatsevtik preparatni ro'yxatdan o'tkazish uchun validatsiyalangan analitik usullar va farmakopeyasi standartlarini ishlab chiqish muqarrar zaruratdir.

«GEPA-SEEM» (QK MAS'UL. JAM. «SAMARKAND-ENGLAND ECO-MEDICAL», O'zbekiston) — uch faol farmatsevtik ingredientni o'z ichiga olgan yangi kombinatsiyalangan infuzion eritma: monoammoniy glitsirrizinati (MAG, 0,8 mg/ml), glitsin (8,0 mg/ml) va L-sistein gidroxlorid (0,6 mg/ml). MAG gepatotsitlarga nisbatan yaqqol yallig'lanishga qarshi, antioksidant va membranani barqarorlashtiruvchi ta'sir ko'rsatadi [3]. Glitsin jigarning detoksikatsiya reaksiyalarida ishtirok etadigan aminokislota bo'lib, sitoprotektiv xususiyatlarga ega [4]. L-sistein gidroxlorid — oltingugurt tutuvchi aminokislota bo'lib, glutationning prekursori sifatida hujayralarda antioksidant himoyani ta'minlaydi [5]. Ushbu komponentlarning sinergik ta'siri turli etiologiyali jigar kasalliklarida preparatning terapevtik ahamiyatini belgilaydi.

Adabiyotlarda kombinatsiyalangan infuzion matriksda uchala FFIni bir vaqtda yoki ketma-ket aniqlash uchun validatsiyalangan miqdoriy YUXXS usuli mavjud emasligi aniqlandi. Ushbu tadqiqotda ikkita spetsifik YUXXS usulini ishlab chiqish, ularni ICH Q2(R1) [6] bo'yicha to'liq validatsiya qilish va «GEPA-SEEM» uchun korxona farmakopeyasi maqolasini belgilash maqsadlari ko'zlangan.

Published

2026-11-17

How to Cite

Tugizboev, S. U., Toshev, G. K., Toshtemirova, C. T., Umirdinova, V. G., & Xazratqulova, S. M. (2026). DETERMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS IN A COMBINED INFUSION SOLUTION BY HPLC: METHOD DEVELOPMENT AND VALIDATION. Journal of Chemistry of Goods and Traditional Medicine, 5(5), 274–300. https://doi.org/10.55475/jcgtm/vol5.iss5.2026.700

Issue

Section

Traditional Medicine

Categories

Similar Articles

<< < 8 9 10 11 12 13 14 15 16 17 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.
Loading...